Premotor Cortex: A New Target for Stroke Motor Rehabilitation

NCT ID: NCT02565199

Last Updated: 2023-08-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

SUSPENDED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-09-30

Study Completion Date

2024-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of the study is to determine the effect of repetitive transcranial magnetic stimulation (rTMS) over the premotor cortex on training-related improvements in motor performance and associated neural plasticity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Motor training is an important part of recovery after stroke. During motor training, stroke patients practice performing a movement and become better at performing the trained movement over time. Repetitive transcranial magnetic stimulation (rTMS), which uses magnetism to excite neurons near the surface of the brain, may further improve performance. Healthy adults made larger training-related improvements in their motor performance when they received rTMS over the primary motor cortex during motor training. There is evidence that the premotor cortex may be a more effective target than the primary motor cortex for rTMS for some stroke survivors. In the current study, the investigator will determine the effect of rTMS over the premotor cortex on training-related improvements in motor performance in healthy adults.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single motor training only

For a pilot experiment, healthy, right-handed subjects will complete one testing session. During the testing session, subjects will complete motor training. The results of this experiment will determine the motor training protocol used in the main experiment.

Group Type EXPERIMENTAL

Motor Training

Intervention Type OTHER

During motor training, participants will quickly extend their hand at a pace of one extension every 5 seconds (0.2Hz) in response to an auditory cue.

Repetitive TMS during motor training

Healthy, right-handed subjects will complete five testing sessions. During each testing session, subjects will complete motor training while receiving one of five repetitive transcranial magnetic stimulation (rTMS) protocols. Subjects will receive a different rTMS protocol at each testing session. By the end of the study, each subject will have received all rTMS protocols.

Group Type EXPERIMENTAL

rTMS over Premotor Cortex (Contralateral Hemisphere)

Intervention Type DEVICE

* Location of rTMS: premotor cortex
* Frequency of rTMS: 0.1 Hz
* Time of rTMS: 50 milliseconds before the onset of movement-related EMG
* Device: MagStim Super Rapid 2 Transcranial Magnetic Stimulator

rTMS over Premotor Cortex (Ipsilateral Hemisphere)

Intervention Type DEVICE

* Location of rTMS: premotor cortex
* Frequency of rTMS: 0.1 Hz
* Time of rTMS: 50 milliseconds before the onset of movement-related EMG
* Device: Super Rapid 2 Transcranial Magnetic Stimulator

rTMS (Control 1)

Intervention Type DEVICE

* Location of rTMS: premotor cortex
* Frequency of rTMS: 0.1 Hz
* Time of rTMS: 400 milliseconds after the onset of movement-related EMG
* Device: Super Rapid 2 Transcranial Magnetic Stimulator

rTMS (Control 2)

Intervention Type DEVICE

* Location of rTMS: somatosensory cortex
* Frequency of rTMS: 0.1 Hz
* Time of rTMS: 50 milliseconds before the onset of movement-related EMG
* Device: Super Rapid 2 Transcranial Magnetic Stimulator

rTMS (Control 3)

Intervention Type DEVICE

* Location of rTMS: premotor cortex
* Frequency of rTMS: 0.1 Hz
* Time of rTMS: 50 milliseconds before the onset of movement-related EMG
* Device: Super Rapid 2 Transcranial Magnetic Stimulator with Sham Coil

Motor Training

Intervention Type OTHER

During motor training, participants will quickly extend their hand at a pace of one extension every 5 seconds (0.2Hz) in response to an auditory cue.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

rTMS over Premotor Cortex (Contralateral Hemisphere)

* Location of rTMS: premotor cortex
* Frequency of rTMS: 0.1 Hz
* Time of rTMS: 50 milliseconds before the onset of movement-related EMG
* Device: MagStim Super Rapid 2 Transcranial Magnetic Stimulator

Intervention Type DEVICE

rTMS over Premotor Cortex (Ipsilateral Hemisphere)

* Location of rTMS: premotor cortex
* Frequency of rTMS: 0.1 Hz
* Time of rTMS: 50 milliseconds before the onset of movement-related EMG
* Device: Super Rapid 2 Transcranial Magnetic Stimulator

Intervention Type DEVICE

rTMS (Control 1)

* Location of rTMS: premotor cortex
* Frequency of rTMS: 0.1 Hz
* Time of rTMS: 400 milliseconds after the onset of movement-related EMG
* Device: Super Rapid 2 Transcranial Magnetic Stimulator

Intervention Type DEVICE

rTMS (Control 2)

* Location of rTMS: somatosensory cortex
* Frequency of rTMS: 0.1 Hz
* Time of rTMS: 50 milliseconds before the onset of movement-related EMG
* Device: Super Rapid 2 Transcranial Magnetic Stimulator

Intervention Type DEVICE

rTMS (Control 3)

* Location of rTMS: premotor cortex
* Frequency of rTMS: 0.1 Hz
* Time of rTMS: 50 milliseconds before the onset of movement-related EMG
* Device: Super Rapid 2 Transcranial Magnetic Stimulator with Sham Coil

Intervention Type DEVICE

Motor Training

During motor training, participants will quickly extend their hand at a pace of one extension every 5 seconds (0.2Hz) in response to an auditory cue.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Motor training only (pilot participants):

* Have the ability to give informed, written consent
* Be aged 18-80 years old
* Be right-handed using the Edinburgh handedness inventory
* Have intact cognitive abilities (score higher than 75th percentile on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS))
* No current depression (score less than 7 on the Hamilton Depression Rating Scale (HDRS))
* No neurological disease
* No contradictions to Transcranial Magnetic Stimulation (TMS)
* TMS over the extensor carpi ulnaris (ECU) hotspot must evoke a motor evoked potential (MEP) in the ECU muscle
* MEP amplitude must increase by at least 20% as the TMS intensity increases
* The subjects must be comfortable when receiving TMS of all strengths.

Remaining study participants:

* Have the ability to give informed, written consent
* Be aged 55-80 years old
* Be right-handed using the Edinburgh handedness inventory
* Have intact cognitive abilities (score higher than 75th percentile on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS))
* No current depression (score less than a 7 on the Hamilton Depression Rating Scale (HDRS))
* No neurological disease
* No contradictions to Transcranial Magnetic Stimulation (TMS)
* TMS over the extensor carpi ulnaris (ECU) hotspot must be able to evoke a motor evoked potential (MEP) in the ECU muscle
* MEP amplitude must increase by at least 20% as the TMS intensity increases
* The subjects must be comfortable when receiving TMS of all strengths.

Exclusion Criteria

* Impaired cognitive abilities (score lesser than 75th percentile on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS))
* Current depression (score more than 7 on the Hamilton Depression Rating Scale (HDRS))
* Neurological disease
* Has a contradiction to TMS
* MEP cannot be evoked with TMS in the ECU muscle
* Inability to tolerate one or more TMS strengths
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

American Heart Association

OTHER

Sponsor Role collaborator

Emory University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cathrin Buetefisch

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Emory University

Atlanta, Georgia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB00081901

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Spatial-Motor Stroke-Rehab Study
NCT06053320 RECRUITING NA